Nucynta 100 MG tablet 100S
Ended Awarded Last action
- Contract number
- SPE2DR26FQR0Z
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,020
Award facts
- Contract value 100% obligated
- $25,020.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25,020.02 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Nucynta 100 mg tablets (100-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 2, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as the primary pharmaceutical supply vehicle for federal military and healthcare operations.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through the DLA's Medical Supply Chain. The company's extensive contract portfolio with the Defense Logistics Agency demonstrates its capability to deliver a comprehensive range of pharmaceutical products across multiple therapeutic domains to support military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government entities. Nucynta (tapentadol) is a centrally acting synthetic analgesic used for pain management, consistent with AmerisourceBergen's established role in supplying pain management pharmaceuticals and other critical medications to federal healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FQR0Z?
SPE2DR26FQR0Z was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FQR0Z worth?
The government has obligated $25,020 on SPE2DR26FQR0Z.
Is contract SPE2DR26FQR0Z an order under another contract?
Yes. SPE2DR26FQR0Z is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQR0Z competed?
The extent of competition for SPE2DR26FQR0Z was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award